Navigation Links
Injury Law Firm Releases New Informational Graphic on the Alleged Birth Defect Risks of Dangers of Topamax

(PRWEB) July 29, 2013

Topamax (topiramate) is a drug used to treat epilepsy and prevent migraines. It has also been used for off-label weight loss for many years and recently the FDA approved a combination of topiramate and phentermine for weight loss. In 1996, the FDA approved Topamax for manufacture and marketing by McNeil Pharmaceuticals and Janssen Pharmaceuticals, which are both owned by Johnson & Johnson. Since the drug’s introduction to the market, it has earned billions of dollars in sales. In fact, the FDA has reported that between January 2007 and December 2010 approximately 32.3 million prescriptions were filled by 4.3 million people (i).

In March 2011, the FDA issued a Drug Safety Communication about a potential link between Topamax use in pregnancy and birth defects. It stated that “there is an increased risk for the development of cleft lip and/or cleft palate (oral clefts) in infants born to women treated with topiramate (Topamax and generic products) during pregnancy.” The FDA also added the drug to Pregnancy Category D meaning “there is positive evidence of human fetal risk based on human data.” It based this change on data from the North American Antiepileptic Drug Pregnancy Registry and a previous analysis of adverse events (i). According to a June 2010 Safety Review of the drug, the FDA had received 67 reports of birth defects including 21 facial defects (11 reports of cleft lip/palate), 19 malformations, and 15 cardiovascular defects (ii). Women who have used this drug and given birth to a child with a birth defect should talk to a drug lawyer about filing a lawsuit.

Recent reports show that Johnson & Johnson had to pay a multi-million dollar settlement and now faces at least 75 birth defect lawsuits due to the promotion and selling of Topamax. In April 2010, the U.S. Department of Justice announced that Johnson & Johnson affiliates, Janssen and McNeil, agreed to pay an $81 million settlement. The agreement was reached in order to settle allegations that the companies had illegally promoted the drug for “unapproved” or “off-label” uses. The Department stated that this “unlawful marketing undermines the FDA’s important role in deciding which drugs are safe and effective for consumers and costs the taxpayers billions of dollars each year" (iii). Also, Johnson & Johnson acknowledged in its most recent annual report that it was facing at least 75 birth defect lawsuits related to this drug (iv).

The new informational graphic provides information on the drug’s side effects as well as a timeline. Visit the webpage and view the Topamax infographic. d’Oliveira & Associates is currently working with some of the more experienced Topamax lawyers in the country who are handling these birth defect lawsuits. Contact the law firm to receive a free legal consultation and there is no fee unless you receive a settlement or award. Call toll-free at 1-800-922-6878 or fill out a contact form on their website in confidence.

(i) Drug Safety Communication, March 4, 2011.
(ii) Safety Review: Topirmate Use During Pregnancy, June 1, 2010.
(iii) U.S. Department of Justice Press Release, April 29, 2010.
(iv) Johnson & Johnson 2012 Annual Report

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Injury and Disability Lawyers Release New Informational Graphic about the Link Between Asbestos and Mesothelioma
2. Law School Student Wins Michigan Personal Injury Law Firm’s Diversity Scholarship
3. Injury Claims against Skechers Toning Shoes Settled or In Process, Says Attorney Robert Jenner
4. Injury Lawyers Release New Infographic and Video about the Antidepressant Zoloft and Its Alleged Dangers
5. Injury Law Firm Releases New Informational Graphic about Workers’ Compensation in Rhode Island
6. The Berman Law Firm Now Offers Legal Consultations for All Car, Truck, Motorcycle Crash Victims and Personal Injury Cases in Kendall, FL
7. Legal Consultations for All Car, Truck, Motorcycle Crash Victims and Personal Injury Cases Are Now Offered By The Berman Law Group in Delray Beach, FL
8. Michigan Personal Injury Lawyers Announce Winner of 2013 Buckfire & Buckfire Diversity Scholarship
9. Sunrise FL Car Accident Lawyers The Berman Law Firm Now Offer Legal Consultations for All Car, Truck, Motorcycle Crash Victims and Personal Injury Cases
10. Mahir Reiss Issues Comment On Injury Prevention Strategies
11. Changes in hyaluronan metabolism key in adaptation of keratinocytes to radiation injury
Post Your Comments:
(Date:11/25/2015)... OK (PRWEB) , ... November 25, 2015 , ... On ... International training center for the Narconon network, announced the release of a new cutting ... 1966 the Narconon organization has been working with drug- and alcohol-addicted individuals with the ...
(Date:11/25/2015)... ... , ... On November 23rd 2015 Cozy Products, a division of ... Cozy Products explains what this means for business moving forward. , The Tri Lite ... business model: to sell personal heaters that reduce energy consumption, are economical and keep ...
(Date:11/25/2015)... ... November 25, 2015 , ... Beddit® has launched a new ... systems. The new app features a more intuitive SleepScore™ that rates sleep quality on ... slept. The SleepScore is created by a proprietary algorithm. Beddit analyzes the data to ...
(Date:11/25/2015)... ... 25, 2015 , ... “While riding the bus, I saw a passenger in ... there had to be a convenient and comfortable way to protect them from bad ... individuals to safely travel during cold or inclement weather. In doing so, it ensures ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible for advancing care ... disease. The Periwinkle Pioneers, nominated by the public, will receive special recognition throughout ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... 26, 2015 ) ... Administration of High Viscosity Drugs" report to ... announced the addition of the "Self Administration ... offering. --> Research and Markets ( ... "Self Administration of High Viscosity Drugs" ...
(Date:11/25/2015)... total global healthcare industry is expected to grow at a ... has the highest projected growth at 12.7%, and ... ), is second with growth projected at 11.5%. ... In 2013-2014, total government funded healthcare was nearly 68%. Federal ... in 2013-2014. In real terms, out of pocket expenditure increased ...
(Date:11/25/2015)... , Nov. 25, 2015 On ... first federal bellwether trial against Wright Medical Technology, ... to their Conserve metal-on-metal hip implant device, awarded ... Following a two week trial and three days ... metal-on-metal hip device was defectively designed and unreasonably ...
Breaking Medicine Technology: